E6 and E7 of human papillomavirus type 18 and UVB irradiation corporately regulate interleukin-6 and interleukin-8 expressions in basal cell carcinoma

Experimental Dermatology

Volumn 22, Issue 10, 2013, Pages 672-674

  Hsiao, Yu Ping ^a,b   Yang, Jen Hung ^c,d   Wu, Wen Jun ^b   Lin, Meng Hsuan ^b   Sheu, Gwo Tarng ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

BCC; HPV; IL 6; IL 8; VUB

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; PROTEIN E6; PROTEIN E7; PROTEIN P53;

ARTICLE; BASAL CELL CARCINOMA; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; KERATINOCYTE; LONG TERM EXPOSURE; MITOSIS INHIBITION; PROTEIN EXPRESSION; RADIATION EXPOSURE; RNA INTERFERENCE; SKIN CARCINOGENESIS; ULTRAVIOLET B RADIATION;

BCC; HPV; IL-6; IL-8; VUB;

CARCINOMA, BASAL CELL; CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SKIN NEOPLASMS; ULTRAVIOLET RAYS; UP-REGULATION;

EID: 84884725321     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12223     Document Type: Article

References (26)

1. Preston D S, Stern R S. N Engl J Med 1992: 327: 1649-1662.
2. Gallagher R P, Hill G B, Bajdik C D et al. Arch Dermatol 1995: 131: 157-163.
3. Dessinioti C, Antoniou C, Katsambas A et al. Photochem Photobiol 2010: 86: 481-491.
4. Madan V, Hoban P, Strange R C et al. Br J Dermatol 2006: 154(Suppl 1): 5-7.
5. Walther U, Kron M, Sander S et al. Br J Dermatol 2004: 151: 170-178.
6. Skellett A M, Hafiji J, Greenberg D C et al. Clin Exp Dermatol 2012: 37: 227-229.
7. Greinert R, Boniol M. Prog Biophys Mol Biol 2011: 107: 473-476.
8. Dessinioti C, Tzannis K, Sypsa V et al. Exp Dermatol 2011: 20: 622-626.
9. Harwood C A, Proby C M. Curr Opin Infect Dis 2002: 15: 101-114.
10. Harwood C A, Spink P J, Surentheran T et al. J Invest Dermatol 1998: 111: 123-127.
11. Iannacone M R, Gheit T, Waterboer T et al. Cancer Epidemiol Biomarkers Prev 2012: 21: 1303-1313.
12. Patel A S, Karagas M R, Perry A E et al. J Invest Dermatol 2008: 128: 2888-2893.
13. Pierceall W E, Goldberg L H, Ananthaswamy H N. J Invest Dermatol 1991: 97: 880-884.
14. Iftner A, Klug S J, Garbe C et al. Cancer Res 2003: 63: 7515-7519.
15. Biliris K A, Koumantakis E, Dokianakis D N et al. Cancer Lett 2000: 161: 83-88.
16. Iannacone M R, Gheit T, Waterboer T et al. J Invest Dermatol 2013: 133: 1512-1520.
17. Purdie K J, Pennington J, Proby C M et al. EMBO J 1999: 18: 5359-5369.
18. Dell'oste V, Azzimonti B, Mondini M et al. J Gen Virol 2008: 89: 2461-2466.
19. Strickland I, Rhodes L E, Flanagan B F et al. J Invest Dermatol 1997: 108: 763-768.
20. Kupper T S, Edelson R L. J Dermatol 1987: 14: 517-523.
21. Kondo S, Kono T, Sauder D N et al. J Invest Dermatol 1993: 101: 690-694.
22. Yen H T, Chiang L C, Wen K H et al. Arch Dermatol Res 1996: 288: 157-161.
23. Tomlins C, Storey A. Carcinogenesis 2010: 31: 2155-2164.
24. McLaughlin-Drubin M E, Munger K. Virus Res 2009: 143: 195-208.
25. Wang G Y, Wang J, Mancianti M L et al. Cancer Cell 2011: 19: 114-124.
26. Guerrini J S, Bouvard V, Oswald E et al. Exp Dermatol 2011: 20: 71-73.